The Supreme Court's interpretation of Article 21 includes the 'Right to Die with Dignity', but this is strictly limited to passive euthanasia for terminally ill patients in an irreversible state, allowing them to refuse life-sustaining treatment. It explicitly does not extend to a general 'Right to Die' or 'Right to Suicide', which remains illegal in India. The distinction is about dignity in dying when life is no longer meaningful, not about ending life at will.

After the 2023 modifications, the JMFC's direct role in approving the withdrawal of treatment has been significantly reduced. Their primary function is now limited to attesting the 'living will' or advance directive made by a competent person. This attestation ensures the authenticity and voluntariness of the document, but the decision to actually withdraw treatment now primarily rests with the medical boards and family/guardians, under strict guidelines.

The Aruna Shanbaug case was landmark because, for the first time, the Supreme Court recognized the concept of passive euthanasia in India. Although permission to withdraw life support for Aruna Shanbaug was denied due to specific circumstances (lack of a 'living will' and opposition from hospital staff who were her de facto guardians), the ruling laid down detailed guidelines for passive euthanasia, establishing it as a legally permissible option under strict judicial oversight. It affirmed that the 'Right to Life' under Article 21 includes the 'Right to Die with Dignity'.

A 'living will' or 'advance directive' is a legal document made by a competent person in advance, stating their wish to refuse life-sustaining treatment if they fall into an irreversible terminal illness or a persistent vegetative state (PVS). It empowers an individual's autonomy by allowing them to make end-of-life decisions while they are still capable, ensuring their wishes are respected even when they can no longer communicate. Without it, decisions for incompetent patients typically fall to family/legal guardians and medical boards, potentially leading to prolonged suffering or conflicts over what the patient would have wanted.

This clarification is crucial because, historically, there was a debate whether CANH (like feeding tubes) was basic sustenance or medical treatment. By classifying it as 'medical treatment', its withdrawal falls squarely under the ambit of passive euthanasia. This resolves the misconception that removing a feeding tube is simply denying food, rather than withdrawing a medical intervention. It ensures that decisions regarding CANH withdrawal are subject to the same strict safeguards and principles of patient autonomy and medical futility as other life-sustaining treatments.

For incompetent patients without a living will, the 'best interest principle' is applied. This involves a holistic evaluation to determine if prolonging life through treatment truly serves their best interest. Beyond medical reports, factors considered include:

• •Substituted Judgment: What the patient would have wanted if they were competent, based on their known values, beliefs, and past statements.
• •Quality of Life: The patient's current and projected quality of life, considering their pain, suffering, and ability to interact with their environment.
• •Family Input: The views of the patient's family or legal guardians, who are presumed to have the patient's best interests at heart.
• •Ethical Considerations: The ethical implications of continuing or withdrawing treatment, ensuring dignity and minimizing suffering.

Passive euthanasia has faced practical implementation challenges due to several factors. The Supreme Court itself has noted the "prolonged absence of comprehensive legislation," which leaves a vacuum and relies solely on judicial guidelines. This leads to:

• •Lack of Awareness: Limited public and even medical professional awareness about the legal provisions and procedures for passive euthanasia and living wills.
• •Procedural Complexities: Even with 2023 modifications, the process involving multiple medical boards and legal formalities can still be daunting for families in distress.
• •Ethical and Moral Dilemmas: Doctors and families often grapple with deep-seated ethical, moral, and religious beliefs against ending life, even passively.
• •Fear of Legal Repercussions: Hospitals and doctors fear potential legal challenges or accusations of negligence, leading to reluctance in implementing the guidelines.
• •Absence of a Centralized Registry: No easy way to register or access living wills, making their enforcement difficult.

The current legal framework incorporates several safeguards: While these safeguards are robust on paper, their sufficiency is debatable. Critics point to potential gaps like the difficulty in truly ascertaining a patient's 'best interest' or the possibility of family pressure, especially in a socio-economic context where healthcare costs are high. Further, the lack of widespread awareness and accessible legal aid might still leave vulnerable individuals susceptible.

• •Medical Board Scrutiny: Two independent medical boards (Primary and Secondary, including external experts) must certify the irreversibility of the patient's condition.
• •Living Will Authenticity: For patients with a living will, a JMFC attests its authenticity and voluntariness.
• •Family Consent: For incompetent patients without a living will, consent from family or legal guardians is essential, guided by the 'best interest principle'.
• •High Court Oversight (Pre-2023): Earlier, High Court approval was required, which was a significant check. Though reduced post-2023, the underlying principle of judicial oversight remains.

As part of a parliamentary committee, I would propose a comprehensive central legislation that codifies the Supreme Court's guidelines, making them statutory law. Challenges would include overcoming deeply ingrained ethical and religious opposition, ensuring data privacy for the digital registry, and achieving consensus among diverse political and social groups on such a sensitive issue.

• •National Registry for Living Wills: Establish a secure, accessible national digital registry for living wills, linked to Aadhaar, ensuring easy verification and reducing reliance on physical documents.
• •Standardized Medical Board Protocols: Mandate uniform, clear protocols for medical boards across all states, including training for doctors on end-of-life care ethics and legal aspects.
• •Public Awareness Campaigns: Launch nationwide public awareness campaigns in regional languages about living wills and passive euthanasia, demystifying the process.
• •Legal Aid and Counseling: Provide mandatory legal aid and counseling services for families considering passive euthanasia, especially for incompetent patients.

India's approach, rooted in the 'Right to Die with Dignity' (Article 21), strictly permits only passive euthanasia under judicial safeguards. This contrasts sharply with countries like the Netherlands, Belgium, or Canada, where active euthanasia or physician-assisted suicide (PAS) is legal. India's stance is underpinned by several ethical considerations: the sanctity of life, the 'do no harm' principle in medicine (Hippocratic oath), and concerns about potential misuse, coercion, or the slippery slope argument (where passive euthanasia could lead to active forms). The judiciary has chosen a cautious path, balancing individual autonomy with societal values and the protection of vulnerable lives, rather than endorsing direct life-ending interventions.

• •India (Passive Euthanasia): Focuses on allowing natural death by withdrawing futile life support, emphasizing dignity when life is no longer meaningful. It's an omission, not a direct act.
• •Other Countries (Active Euthanasia/PAS): Involves a direct act by a physician to end life (active euthanasia) or providing means for the patient to do so (PAS).

The Supreme Court's interpretation of Article 21 includes the 'Right to Die with Dignity', but this is strictly limited to passive euthanasia for terminally ill patients in an irreversible state, allowing them to refuse life-sustaining treatment. It explicitly does not extend to a general 'Right to Die' or 'Right to Suicide', which remains illegal in India. The distinction is about dignity in dying when life is no longer meaningful, not about ending life at will.

After the 2023 modifications, the JMFC's direct role in approving the withdrawal of treatment has been significantly reduced. Their primary function is now limited to attesting the 'living will' or advance directive made by a competent person. This attestation ensures the authenticity and voluntariness of the document, but the decision to actually withdraw treatment now primarily rests with the medical boards and family/guardians, under strict guidelines.

The Aruna Shanbaug case was landmark because, for the first time, the Supreme Court recognized the concept of passive euthanasia in India. Although permission to withdraw life support for Aruna Shanbaug was denied due to specific circumstances (lack of a 'living will' and opposition from hospital staff who were her de facto guardians), the ruling laid down detailed guidelines for passive euthanasia, establishing it as a legally permissible option under strict judicial oversight. It affirmed that the 'Right to Life' under Article 21 includes the 'Right to Die with Dignity'.

A 'living will' or 'advance directive' is a legal document made by a competent person in advance, stating their wish to refuse life-sustaining treatment if they fall into an irreversible terminal illness or a persistent vegetative state (PVS). It empowers an individual's autonomy by allowing them to make end-of-life decisions while they are still capable, ensuring their wishes are respected even when they can no longer communicate. Without it, decisions for incompetent patients typically fall to family/legal guardians and medical boards, potentially leading to prolonged suffering or conflicts over what the patient would have wanted.

This clarification is crucial because, historically, there was a debate whether CANH (like feeding tubes) was basic sustenance or medical treatment. By classifying it as 'medical treatment', its withdrawal falls squarely under the ambit of passive euthanasia. This resolves the misconception that removing a feeding tube is simply denying food, rather than withdrawing a medical intervention. It ensures that decisions regarding CANH withdrawal are subject to the same strict safeguards and principles of patient autonomy and medical futility as other life-sustaining treatments.

For incompetent patients without a living will, the 'best interest principle' is applied. This involves a holistic evaluation to determine if prolonging life through treatment truly serves their best interest. Beyond medical reports, factors considered include:

• •Substituted Judgment: What the patient would have wanted if they were competent, based on their known values, beliefs, and past statements.
• •Quality of Life: The patient's current and projected quality of life, considering their pain, suffering, and ability to interact with their environment.
• •Family Input: The views of the patient's family or legal guardians, who are presumed to have the patient's best interests at heart.
• •Ethical Considerations: The ethical implications of continuing or withdrawing treatment, ensuring dignity and minimizing suffering.

Passive euthanasia has faced practical implementation challenges due to several factors. The Supreme Court itself has noted the "prolonged absence of comprehensive legislation," which leaves a vacuum and relies solely on judicial guidelines. This leads to:

• •Lack of Awareness: Limited public and even medical professional awareness about the legal provisions and procedures for passive euthanasia and living wills.
• •Procedural Complexities: Even with 2023 modifications, the process involving multiple medical boards and legal formalities can still be daunting for families in distress.
• •Ethical and Moral Dilemmas: Doctors and families often grapple with deep-seated ethical, moral, and religious beliefs against ending life, even passively.
• •Fear of Legal Repercussions: Hospitals and doctors fear potential legal challenges or accusations of negligence, leading to reluctance in implementing the guidelines.
• •Absence of a Centralized Registry: No easy way to register or access living wills, making their enforcement difficult.

The current legal framework incorporates several safeguards: While these safeguards are robust on paper, their sufficiency is debatable. Critics point to potential gaps like the difficulty in truly ascertaining a patient's 'best interest' or the possibility of family pressure, especially in a socio-economic context where healthcare costs are high. Further, the lack of widespread awareness and accessible legal aid might still leave vulnerable individuals susceptible.

• •Medical Board Scrutiny: Two independent medical boards (Primary and Secondary, including external experts) must certify the irreversibility of the patient's condition.
• •Living Will Authenticity: For patients with a living will, a JMFC attests its authenticity and voluntariness.
• •Family Consent: For incompetent patients without a living will, consent from family or legal guardians is essential, guided by the 'best interest principle'.
• •High Court Oversight (Pre-2023): Earlier, High Court approval was required, which was a significant check. Though reduced post-2023, the underlying principle of judicial oversight remains.

As part of a parliamentary committee, I would propose a comprehensive central legislation that codifies the Supreme Court's guidelines, making them statutory law. Challenges would include overcoming deeply ingrained ethical and religious opposition, ensuring data privacy for the digital registry, and achieving consensus among diverse political and social groups on such a sensitive issue.

• •National Registry for Living Wills: Establish a secure, accessible national digital registry for living wills, linked to Aadhaar, ensuring easy verification and reducing reliance on physical documents.
• •Standardized Medical Board Protocols: Mandate uniform, clear protocols for medical boards across all states, including training for doctors on end-of-life care ethics and legal aspects.
• •Public Awareness Campaigns: Launch nationwide public awareness campaigns in regional languages about living wills and passive euthanasia, demystifying the process.
• •Legal Aid and Counseling: Provide mandatory legal aid and counseling services for families considering passive euthanasia, especially for incompetent patients.

India's approach, rooted in the 'Right to Die with Dignity' (Article 21), strictly permits only passive euthanasia under judicial safeguards. This contrasts sharply with countries like the Netherlands, Belgium, or Canada, where active euthanasia or physician-assisted suicide (PAS) is legal. India's stance is underpinned by several ethical considerations: the sanctity of life, the 'do no harm' principle in medicine (Hippocratic oath), and concerns about potential misuse, coercion, or the slippery slope argument (where passive euthanasia could lead to active forms). The judiciary has chosen a cautious path, balancing individual autonomy with societal values and the protection of vulnerable lives, rather than endorsing direct life-ending interventions.

• •India (Passive Euthanasia): Focuses on allowing natural death by withdrawing futile life support, emphasizing dignity when life is no longer meaningful. It's an omission, not a direct act.
• •Other Countries (Active Euthanasia/PAS): Involves a direct act by a physician to end life (active euthanasia) or providing means for the patient to do so (PAS).